Cargando…

Huntington’s Disease and Striatal Signaling

Huntington’s Disease (HD) is the most frequent neurodegenerative disease caused by an expansion of polyglutamines (CAG). The main clinical manifestations of HD are chorea, cognitive impairment, and psychiatric disorders. The transmission of HD is autosomal dominant with a complete penetrance. HD has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roze, Emmanuel, Cahill, Emma, Martin, Elodie, Bonnet, Cecilia, Vanhoutte, Peter, Betuing, Sandrine, Caboche, Jocelyne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188786/ https://www.ncbi.nlm.nih.gov/pubmed/22007160 http://dx.doi.org/10.3389/fnana.2011.00055

Ejemplares similares

Multiple Aspects of Gene Dysregulation in Huntington’s Disease
por: Moumné, Lara, et al.
Publicado: (2013)

Altered Cholesterol Homeostasis in Huntington’s Disease
por: Kacher, Radhia, et al.
Publicado: (2022)

Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter
por: Martin, Elodie, et al.
Publicado: (2011)

Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse
por: Cahill, Emma, et al.
Publicado: (2014)

Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation
por: Deyts, Carole, et al.
Publicado: (2009)

Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum
por: Pinchaud, Katleen, et al.
Publicado: (2023)

Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020)

Elk-1 a Transcription Factor with Multiple Facets in the Brain
por: Besnard, Antoine, et al.
Publicado: (2011)

Proteostasis in striatal cells and selective neurodegeneration in Huntington’s disease
por: Margulis, Julia, et al.
Publicado: (2014)

Striatal Network Models of Huntington's Disease Dysfunction Phenotypes
por: Zheng, Pengsheng, et al.
Publicado: (2017)

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease
por: Boussicault, Lydie, et al.
Publicado: (2016)

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease
por: Nóbrega, Clévio, et al.
Publicado: (2020)

Preserving cortico-striatal function: deep brain stimulation in Huntington’s disease
por: Nagel, Sean J., et al.
Publicado: (2015)

Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington’s Disease
por: Serranilla, Melissa, et al.
Publicado: (2022)

Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease
por: Kim, Anya, et al.
Publicado: (2020)

BACHD Mice Recapitulate the Striatal Parvalbuminergic Interneuron Loss Found in Huntington’s Disease
por: Rallapalle, Vyshnavi, et al.
Publicado: (2021)

Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease
por: André, Véronique M., et al.
Publicado: (2011)

A Commentary on: “Preserving cortico-striatal function: Deep Brain Stimulation in Huntington's disease”
por: Tolleson, Christopher M.
Publicado: (2015)

Mislocalization of Nucleocytoplasmic Transport Proteins in Human Huntington’s Disease PSC-Derived Striatal Neurons
por: Lange, Jenny, et al.
Publicado: (2021)

Reactive Neuroblastosis in Huntington’s Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain
por: Kandasamy, Mahesh, et al.
Publicado: (2018)

Differential Alteration in Expression of Striatal GABA(A)R Subunits in Mouse Models of Huntington’s Disease
por: Du, Zhuowei, et al.
Publicado: (2017)

Corrigendum: Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington's Disease
por: Serranilla, Melissa, et al.
Publicado: (2022)

Striatal signaling: two decades of progress
por: Valjent, Emmanuel
Publicado: (2012)

Striatal network modeling in Huntington’s Disease
por: Ponzi, Adam, et al.
Publicado: (2020)

Disrupting D1-NMDA or D2-NMDA receptor heteromerization prevents cocaine’s rewarding effects but preserves natural reward processing
por: Andrianarivelo, Andry, et al.
Publicado: (2021)

Striatal spatial heterogeneity, clustering, and white matter association of GFAP(+) astrocytes in a mouse model of Huntington’s disease
por: Brown, Taylor G., et al.
Publicado: (2023)

Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington’s Disease
por: Nguyen, Khanh Q., et al.
Publicado: (2016)

Cell-type- and region-specific modulation of cocaine seeking by micro-RNA-1 in striatal projection neurons
por: Forget, Benoit, et al.
Publicado: (2021)

Altered Regulation of Striatal Neuronal N-Methyl-D-Aspartate Receptor Trafficking by Palmitoylation in Huntington Disease Mouse Model
por: Kang, Rujun, et al.
Publicado: (2019)

Cannabinoid signaling and risk in Huntington's disease
por: Humble, James, et al.
Publicado: (2022)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

The mechanism of degeneration of striatal neuronal subtypes in Huntington disease
por: Rikani, Azadeh A., et al.
Publicado: (2014)

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
por: Morigaki, Ryoma, et al.
Publicado: (2017)

Altered enhancer transcription underlies Huntington’s disease striatal transcriptional signature
por: Le Gras, Stéphanie, et al.
Publicado: (2017)

Editorial: Cholesterol and Neurodegenerative Diseases - Pressing Questions and How to Address Them
por: Betuing, Sandrine, et al.
Publicado: (2022)

Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
por: Wiprich, Melissa Talita, et al.
Publicado: (2021)

D1R- and D2R-Medium-Sized Spiny Neurons Diversity: Insights Into Striatal Vulnerability to Huntington’s Disease Mutation
por: Bergonzoni, Guendalina, et al.
Publicado: (2021)

Altered exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of cultured striatal neurons in a knock-in mouse model of Huntington’s disease
por: Xu, Chen, et al.
Publicado: (2023)

Impaired striatal function in Huntington's disease is due to aberrant p75NTR signaling
por: Plotkin, Joshua L, et al.
Publicado: (2014)

Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ltoei92o7dulofjbi26tv3tncu